LifeNet Health
LifeNet Health is a 40-year-old nonprofit regenerative medicine organization that processes and distributes human tissue allografts across nine surgical categories, runs Virginia's organ procurement operations, and supplies research-grade human cells and tissues to surgeons, hospitals, and pharmaceutical researchers worldwide.
- Company typePrivate
- Founded1984
- HeadquartersVirginia Beach, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What LifeNet Health does
LifeNet Health is a Virginia Beach-based nonprofit organization founded in 1982 that has operated in regenerative medicine for more than 40 years, processing and distributing human tissue allografts, facilitating organ procurement as an Organ Procurement Organization (OPO) in Virginia, and supplying research-grade human cells and tissues through its LifeSciences division. The company serves surgeons and healthcare facilities across nine clinical verticals — cardiac, vascular, sports medicine, orthopedics, trauma, craniomaxillofacial, spine, dental, and wound care — and reports more than 13 million allografts distributed since 1995 with no documented disease transmission. Its Virginia-headquartered operations span more than 1,500 employees globally, with additional production and laboratory sites in the Netherlands, North Charleston (South Carolina), and Kalamazoo (Michigan).
The company's competitive position rests on two proprietary technology platforms: Matracell decellularization (covered by U.S. Patent 6,743,574), which removes more than 99% of donor cells and DNA while preserving biomechanical strength, and Allowash sterilization, which has processed more than 13 million allografts with a 30-year clean safety record. Product franchises include ViviGen and OraGen viable bone allografts, the PliaFX family of advanced fiber demineralized bone matrices, Nexeon (the world's first room-temperature decellularized vascular graft), Matrion placental membrane for chronic wounds, CardioGraft-MC decellularized pulmonary patches, Dermacell Porous dermal matrix, and the TheraSkin wound-care line acquired from Bioventus. Recent acquisitions of HCM Medical (rebranded LifeNet Health Advanced Xeno-Therapeutics in 2026) and Tissue Testing Technologies (T3) extend the platform into xenografts and vitrification biopreservation, respectively. The regulatory stack — FDA registration, ISO 13485, CLIA, AATB (longest-running accreditation), and UNOS membership — creates a high barrier to entry.
LifeNet Health monetizes primarily through one-time sale of allograft biologics to hospitals and surgeons via a direct enterprise field-sales model, reinforced by a global channel-partner relationship with Johnson & Johnson MedTech for PliaFX Pak. Professional-services revenue streams come from its Virginia-based OPO, tissue donation services, and LifeSciences research contracts (priced at direct cost plus up to 20% overhead). Go-to-market combines dedicated Bio-Implant Specialists embedded with surgeons, 7am–7pm EST customer support with 24-hour on-call emergency coverage, conference presence at AAOS and NASS, and a Global Recovery Network Services (GRNS) partner network that secures donor tissue across regions.
LifeNet Health firmographics
Firmographics- Name
- LifeNet Health
- Legal name
- LifeNet Health, Inc.
- Website
- https://lifenethealth.org
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- LifeNet Health is a 40-year-old nonprofit regenerative medicine organization that processes and distributes human tissue allografts across nine surgical categories, runs Virginia's organ procurement operations, and supplies research-grade human cells and tissues to surgeons, hospitals, and pharmaceutical researchers worldwide.
- Ownership category
- akta.pro rank
LifeNet Health industry classification
Industry- Product category
- Regenerative Medicine & Tissue Banking
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)
- akta.pro secondary industries
- Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Organoids & Organ-on-Chip (regenerative models) (HLAAAGAD)
Keywords
Where LifeNet Health is headquartered
LocationHeadquarters
- HQ city
- Virginia Beach
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
LifeNet Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Allograft Bio-Implants Sales: LifeNet Health generates revenue through the sale of allograft biological implants including bone, tissue, cardiac, vascular, sports medicine, and wound care products to healthcare providers and hospitals.
- Organ Procurement Organization Services: As an OPO, LifeNet Health facilitates organ donation and transplantation services, working with hospitals and transplant centers across Virginia.
- LifeSciences Research Solutions: LifeNet Health LifeSciences provides human cell- and tissue-based research solutions to pharmaceutical and biotechnology companies, supporting drug discovery and development.
- Contract Research Services: As a non-profit, LifeNet Health charges direct costs plus up to 20% overhead for research contract work with outside institutions. Services include non-clinical laboratory research and analytical services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Allograft implant products sold directly to healthcare providers |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
LifeNet Health product offering
Product offeringCore offering
LifeNet Health is a regenerative medicine organization that recovers, processes, and distributes human allograft bio-implants (bone, soft tissue, cardiac, vascular, sports medicine, and wound care grafts) for surgical use. It also operates as an Organ Procurement Organization (OPO) coordinating organ donation for transplantation, and provides research-grade biological materials to life sciences organizations.
Product overview
LifeNet Health is a global leader in regenerative medicine offering a comprehensive portfolio of allograft bio-implants and related services. The product portfolio includes bone allografts (ViviGen, OraGen, PliaFX family including PliaFX Pak, PliaFX Prime, PliaFX Strip, PliaFX Flo), vascular products (Nexeon), wound care solutions (Matrion, Dermacell Porous, TheraSkin, ArthroFlex), cardiac products (CardioGraft-MC), sports medicine constructs (FlexiGraft including QuadLink), and structural allografts (VertiGraft, SymAlign). The company also operates Organ Procurement Organization services, tissue donation services, and LifeSciences research solutions. Key technology platforms include Matracell decellularization technology and Allowash sterilization technology. Recent acquisitions include HCM Medical (now LifeNet Health Advanced Xeno-Therapeutics), Tissue Testing Technologies for biopreservation capabilities, and the wound care division of Bioventus Inc.
Differentiator
Problem solved
Functional benefit
Brands
- Nexeon: Advanced Vascular Allograft - the world's first decellularized, sterile, room temperature vascular allograft.
- Matrion
- LifeNet Health Advanced Xeno-Therapeutics (LifeNet Health AXT)
- LifeNet Health LifeSciences
- TheraSkin
- ViviGen
- PliaFX
- Dermacell
- OraGen
- CardioGraft-MC
Products and services
- Allograft Bio-Implants (Bone & Soft Tissue) Processed human bone and soft tissue allografts used by orthopedic surgeons, hospitals, and surgical centers for reconstructive procedures.
- Cardiac Allografts Human cardiac tissue grafts used by cardiac surgeons for valve replacement and cardiac repair procedures.
- Vascular Allografts Human vascular grafts for vascular surgeons performing bypass and reconstructive vascular procedures.
- Wound Care Allografts Skin and dermal allografts used by wound care specialists and burn centers for chronic wound and burn treatment.
- Organ Procurement & Donation Services Organ Procurement Organization (OPO) services coordinating the recovery and transplantation of organs from deceased donors to recipient hospitals.
- LifeSciences Research Products Research-grade biological materials and tissue samples supplied to academic institutions, biotech, and pharmaceutical companies for R&D.
Quantifiable outcome
- 13 million+ allografts processed with Allowash technology with zero disease transmission since 1995
- +6 more outcomes
Companies that use LifeNet Health
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles2 records
LifeNet Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
LifeNet Health partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, minor and strategic.
- NASA Langley Research CentercoreCollaboration on first-of-its-kind drone kidney transport study. NASA, UNOS, and LifeNet Health successfully completed groundbreaking drone flights transporting human kidneys beyond visual line of sight. Preliminary findings showed no evidence of damage to organs after biopsies and preservation pump assessments.
- United Network for Organ Sharing (UNOS)corePartnership with NASA and LifeNet Health on drone kidney transport study to evaluate organ transportation technology. Goal is to improve reliability, reduce transit times, and expand access to transplantation for the 100,000+ people waiting for transplants in the U.S.
- Tissue Testing Technologies LLC (T3)coreAcquisition of biotech firm specializing in biopreservation. T3's technologies enable vitrification preservation and controlled warming for human and xenograft tissues, improving organ and tissue preservation for transplantation.
- HCM MedicalcoreAcquisition of Netherlands-based contract manufacturing organization to expand access to advanced health technologies and regenerative biologics. Brings closed-herd xenograft platform, antibiotic-coated implant technologies, and next-generation sterilization methods.
- Johnson & Johnson MedTechcorePartnership for demineralized bone matrix products, including PliaFX Pak commercialized through J&J MedTech starting August 2024. Collaboration combines mineralized bone chips with demineralized fibers for orthopedic spine and trauma procedures.
- The Honor FoundationminorPartnership with career transition program for U.S. Special Operations Forces to propel veteran careers into the civilian sector.
- Specialist DirectcoreDeployment of Mobile Telepathology for OPOs to improve organ recovery processes through field-based digital slide transmission for rapid pathology review. Since implementation, achieved 50% reduction in biopsy interpretation times and increased organ transplants by 84.
- Virginia Bioscience Foundation / GO VirginiaminorEducational partnership with Landstown High School and Varina High School providing hands-on laboratory experiences for students to foster interest in life science careers.
- CN BiostrategicLifeNet Health LifeSciences partnership to supply and distribute hepatic cells to CN Bio, a leading organ-on-a-chip company that manufactures single- and multi-organ MPS platforms for drug discovery and safety testing.
- Bioventus Inc. (Wound Care Division)strategicAcquisition of wound care division including TheraSkin products to expand regenerative medicine portfolio and address medical needs of patients with chronic wounds. Acquisition added 90 employees.
Scale indicators9 records
Recent moves7 records
Expansion highlights8 records
LifeNet Health competitors and assessment
Company assessmentDirect peers
- MTF Biologics: Non-profit musculoskeletal transplant foundation that processes and distributes allograft tissue for orthopedics, sports medicine, and wound care. Closest comparable operating model to LifeNet Health (nonprofit OPO-style tissue bank with broad allograft portfolio).
- AlloSource: Non-profit tissue bank specializing in allograft implants for spine, orthopedics, sports medicine, and wound care. Directly competes with LifeNet Health's biologics division across similar surgical specialties and customer segments.
- Bioventus: Public orthobiologics company whose wound care division was acquired by LifeNet Health in 2023. Direct peer in bone graft substitutes, hyaluronic acid, and chronic wound care biologics.
- Anika Therapeutics: Public regenerative medicine company focused on hyaluronic acid-based orthobiologics and surgical regenerative solutions. Comparable target markets in joint preservation, sports medicine, and regenerative soft-tissue repair.
Broad incumbents
- Arthrex: Large private orthopedics and sports medicine medtech with autologous biologics, graft preparation systems, and a deep salesforce in orthobiologics. Broad incumbent competing with LifeNet Health in sports medicine and orthopedic allograft/orthobiologic categories.
- Conmed: Public medical device company with orthopedic, sports medicine, and biologic product lines. Competes with LifeNet Health in sports medicine grafts and orthobiologics as part of a broader surgical portfolio.
- Integra LifeSciences: Public regenerative technology and neurosurgery company with regenerative tissue technologies (Durepair, DuraGen, Integra dermal matrices). Comparable in wound management, dermal matrices, and regenerative surgical implants.
- DePuy Synthes (Johnson & Johnson MedTech): Johnson & Johnson's orthopedics and spine business, which is both a channel partner (commercializing PliaFX Pak) and a broad competitive incumbent in spine, trauma, and orthobiologics. Directly relevant given its dual role as partner and competitor to LifeNet Health.
- Smith+Nephew: Global medical device company with orthopedics, sports medicine, and advanced wound management portfolios, including regenerative skin substitutes. Competes with LifeNet Health in wound care, sports medicine grafts, and orthopedic biologics.
Emerging players
- Vivex Biologics: Emerging orthobiologics player with cellular bone grafts, amniotic membranes, and spine allografts. Niche competitor in the same allograft/regenerative medicine categories where LifeNet Health's ViviGen and PliaFX compete.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
LifeNet Health social profiles
Digital presenceLifeNet Health compliance and trust
Trust signalCompliance7 records
LifeNet Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
LifeNet Health leadership team
Management profileNumber of profiles
LifeNet Health subsidiaries and ownership
Company hierarchySubsidiaries8 records
LifeNet Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LifeNet Health M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LifeNet Health
What does LifeNet Health do?
LifeNet Health is a regenerative medicine organization that recovers, processes, and distributes human allograft bio-implants (bone, soft tissue, cardiac, vascular, sports medicine, and wound care grafts) for surgical use. It also operates as an Organ Procurement Organization (OPO) coordinating organ donation for transplantation, and provides research-grade biological materials to life sciences organizations.
Is LifeNet Health a public or private company?
LifeNet Health is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was LifeNet Health founded?
LifeNet Health was founded in 1984. It employs 1,001 to 5,000 people.
Where is LifeNet Health based?
LifeNet Health is headquartered in Virginia Beach, United States, in the North America region.
How does LifeNet Health make money?
Four revenue lines are on record. Allograft Bio-Implants Sales are the primary driver. The others are organ Procurement Organization Services, lifeSciences Research Solutions and contract Research Services.
Who are LifeNet Health's main competitors?
Direct peers on record are MTF Biologics, AlloSource, Bioventus and Anika Therapeutics. Broad incumbents are Arthrex, Conmed, Integra LifeSciences, DePuy Synthes (Johnson & Johnson MedTech) and Smith+Nephew. Vivex Biologics is listed as an emerging player.
Does LifeNet Health have an API?
No public API is recorded for LifeNet Health.
What industry is LifeNet Health in?
LifeNet Health's product category is Regenerative Medicine & Tissue Banking. Its primary akta.pro industry code is HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration, with a secondary code of BPAGACAJ, Blood, Organ & Tissue Donation Organizations. Its NAICS code is 621991 and its SIC code is 3842.